Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Pharma
J&J eyes earlier myeloma treatment with ph. 3 Tecvayli combo win
J&J says it plans to present the Tecvayli combo data to health authorities and disclose the detailed myeloma results at an upcoming medical meeting.
Fraiser Kansteiner
Oct 16, 2025 8:10am
Amgen's Repatha meets the mark in CV primary prevention trial
Oct 2, 2025 11:26am
Hansa eyes FDA filing after ph. 3 win for kidney transplant med
Sep 25, 2025 12:37pm
Novo pads case for Wegovy in a pill ahead of FDA decision
Sep 18, 2025 9:59am
Fierce Biotech
Zydus' phase 3 win tees up filing to challenge Gilead and Ipsen
Aug 29, 2025 10:59am
Fierce Biotech
Amylyx discontinues rare neuro program after missing ph. 2 mark
Aug 27, 2025 10:40am
